106-OR: A First-in-Human Single Ascending Dose Study of Oxyntomodulin Analog LY3305677 in Healthy Subjects

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 106-OR
Author(s):  
LAI-SAN THAM ◽  
MELISSA K. THOMAS ◽  
CHARLES BENSON ◽  
ROSS BRAY ◽  
CHENG CAI TANG ◽  
...  
Keyword(s):  
Healthy Subjects ◽  
Dose Study ◽  
Single Ascending Dose Study

107-LB: Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1092 in Healthy Subjects (HS)

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 107-LB
Author(s):  
LINDA MORROW ◽  
MICHAEL GRIMM ◽  
CARINE BEYSEN ◽  
GEOFFREY WALFORD ◽  
KELLY DUNCAN ◽  
...  
Keyword(s):  
Healthy Subjects ◽  
Pharmacokinetics And Pharmacodynamics ◽  
Dose Study ◽  
Single Ascending Dose Study

scholarly journals A Double‐Blind, Phase I, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BOS161721 in Healthy Subjects

2019 ◽  
Vol 13 (2) ◽  
pp. 337-344 ◽  
Author(s):  
Azra Hussaini ◽  
Rajat Mukherjee ◽  
Dina M. Berdieva ◽  
Christen Glogowski ◽  
Richard Mountfield ◽  
...  
Keyword(s):  
Phase I ◽  
Healthy Subjects ◽  
Pharmacokinetics And Pharmacodynamics ◽  
Double Blind ◽  
Dose Study ◽  
Single Ascending Dose Study
Sign in / Sign up

Export Citation Format

Share Document